Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

Pacira BioSciences, Inc. Common Stock

Pacira Pharmaceuticals, Inc. focuses on providing non-opioid medications and advanced drug delivery technologies for pain management.

COM:PACIRA

Pacira Pharmaceuticals, Inc.

Last Close

17.38

22/11 21:00

Market Cap

809.53M

Beta: -

Volume Today

495.17K

Avg: -